FAVORITO TAMARA A 4
4 · Kintara Therapeutics, Inc. · Filed Sep 1, 2023
Insider Transaction Report
Form 4
SEYMOUR TAMARA A
Director
Transactions
- Award
Options (Right to Buy)
2023-08-30+8,500→ 8,500 totalExercise: $4.66Exp: 2033-08-30→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on September 30, 2023.